Company
Ann Arbor
Every investor coverage indicates participated in a round UM raised.
Companies UM acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| Professor Dinesh Khanna | Frederick G.L. Huetwell Professor of Rheumatology and Director, Scleroderma Program | Brandon Capital, Brandon BioCatalyst |
Stories naming UM. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Nineteen early-stage companies join Startmate's Summer '26 accelerator intake, each receiving $120,000 for 7% equity — $2.28 million overall — spanning construction, healthcare, fintech, energy and manufacturing.
A year-end list profiling women leaders worldwide, from presidents to tech founders; it recalls Airwallex's landmark capital raise and Mira Murati's new AI venture with its record seed round.
Melbourne biotech Certa Therapeutics reported encouraging Phase 2 results for its scleroderma drug FT011 at a US rheumatology meeting, with safety confirmed and a pivotal trial planned.
Australian biotech Certa Therapeutics reports Phase 2 scleroderma trial results for FT011 at a US rheumatology meeting, showing efficacy and safety, with a pivotal study planned.
Blackbird's investment note announcing it led Forage's US$25 million Series B alongside Lightspeed, Funders Club and new backers, with Tom Humphrey joining the board, plus a profile of Forage's preskilling platform.
Also Startup Daily·Startup Daily·Startup Daily·Forbes Australia
Singapore data firm Near hires Ed Lowther-Harris as Australia and New Zealand managing director and David Raitt as general manager; it has also recently acquired data intelligence specialist UM, formerly UberMedia.